1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant Acinetobacter baumannii
Open Access
- 12 November 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 8 (1) , 27-31
Abstract
With only two new classes of antibiotics developed in the last 40 years, novel antibiotics are desperately needed to combat the growing problem of multidrug-resistant and extensively drug resistant bacteria, particularly Gram-negative bacteria. Described in this letter is the synthesis and antibiotic activity of 1,2,4-triazolidine-3-thiones as narrow spectrum antibiotics. Optimization of the 1,2,4-triazolidine-3-thione scaffold identified a small molecule with potent antibiotic activity against multiple strains of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii. This small molecule also shows single dose, in vivo activity in a Galleria mellonella infection model with A. baumannii and represents a promising start in the development of a class of drugs that can target this bacterial pathogen.Keywords
Funding Information
- Congressionally Directed Medical Research Programs
This publication has 19 references indexed in Scilit:
- 1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial PathogensACS Infectious Diseases, 2016
- Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnosticsTetrahedron, 2016
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyThe Lancet Infectious Diseases, 2016
- Antibiotics: the changing regulatory and pharmaceutical industry paradigmJournal of Antimicrobial Chemotherapy, 2015
- Acinetobacter in modern warfareInternational Journal of Antimicrobial Agents, 2012
- Chemical Genetic Profiling and Characterization of Small-molecule Compounds That Affect the Biosynthesis of Unsaturated Fatty Acids in Candida albicansJournal of Biological Chemistry, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Targeting virulence: a new paradigm for antimicrobial therapyNature Chemical Biology, 2007
- Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of HospitalizationEmerging Infectious Diseases, 2007
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005